全球营养补充和疫苗市场规模、份额、成长分析（按类型、最终用户）- 产业预测，2024-2031 年

Global Nutraceutical & Vaccine Market Size, Share, Growth Analysis, By Type(Nutraceutical and Vaccine), By End-User(Adult and Children) - Industry Forecast 2024-2031

出版日期: 2024年03月18日 | 出版商:

SkyQuest | 英文 202 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球营养补充和疫苗市场规模估值为530.1亿美元，从2023年的570.4亿美元增长到2031年的1024.9亿美元，并预计在预测期内增长（2024年预计复合年增长率为7.60 ） 2031 年至 2031 年的百分比。

近年来，在健康意识不断提高的推动下，全球营养补充和疫苗市场经历了显着增长。营养补充食品机能性食品、营养补充和草药产品组成，由于其潜在的健康益处和预防功效，在消费者对营养食品的认识不断提高的推动下，越来越受到关注。我是。同时，由于人们对疾病预防的兴趣增加、疫苗开发的技术进步以及全球免疫倡议的扩大，疫苗产业的需求正在激增。世界各国政府致力于确保普遍获得疫苗，世界卫生组织 (WHO) 全球疫苗行动计划已得到 194 个成员国的核准。我在这里。政府和非政府组织在加强这一部门方面发挥关键作用，透过定期评估来衡量疫苗接种目标的进展。联合国儿童基金会和世界卫生组织宣布的综合多年计画等倡议旨在促进公平的疫苗取得并加强相关人员的参与。免疫覆盖率的普及，例如白喉、百日咳和破伤风三联疫苗目前广泛应用于全球数百万婴幼儿，是市场强劲表现的关键驱动力，证实了这一趋势。同时，富含必需营养素和抗氧化剂的营养补充因其预防性健康益处而得到越来越多的认可，世界各地的消费者都优先考虑他们的健康并改善医疗保健系统。我们相信可以节省成本并培养健康的人口。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Pfizer Inc.（US）
Johnson & Johnson（US）
Novartis International AG（Switzerland）
Merck & Co., Inc.（US）
GlaxoSmithKline plc（UK）
Sanofi SA（France）
AstraZeneca plc（UK）
Abbott Laboratories（US）
Eli Lilly and Company（US）
Gilead Sciences, Inc.（US）
Amgen Inc.（US）
Bristol Myers Squibb（US）
Moderna, Inc.（US）
Roche Holding AG（Switzerland）
Novo Nordisk A/S（Denmark）
Takeda Pharmaceutical Company Limited（Japan）
Bayer AG（Germany）
Astellas Pharma Inc.（Japan）
Daiichi Sankyo Company, Limited（Japan）
AbbVie Inc.（US）

简介目录

Product Code: SQMIG20I2090

Global Nutraceutical & Vaccine Market size was valued at USD 53.01 billion in 2022 and is poised to grow from USD 57.04 billion in 2023 to USD 102.49 billion by 2031, growing at a CAGR of 7.60% during the forecast period (2024-2031).

The global nutraceutical and vaccine market has experienced remarkable growth recently, driven by increasing awareness of health and wellness benefits. Nutraceuticals, comprising functional foods, dietary supplements, and herbal products, are gaining traction due to their potential health advantages and preventive qualities, fueled by rising consumer consciousness regarding nutrition importance. Concurrently, the vaccine sector has seen a surge in demand, propelled by a heightened focus on disease prevention, technological advancements in vaccine development, and expanding global immunization initiatives. Governments worldwide are committed to ensuring universal access to vaccines, as evidenced by the World Health Organization's 'Global Vaccine Action Plan,' endorsed by 194 member states. With regular evaluations to gauge progress towards vaccination targets, governmental and non-governmental entities play vital roles in bolstering the sector. Initiatives like the comprehensive Multi-Year Plan, published by UNICEF and WHO, aim to promote equitable vaccine access and enhance stakeholder involvement. The growing immunization coverage, exemplified by the widespread administration of the Diphtheria, Pertussis, and Tetanus vaccine to millions of infants globally, underscores the market's flourishing trajectory. Meanwhile, nutraceuticals, enriched with essential nutrients and antioxidants, are increasingly recognized for their preventive health benefits, with consumers worldwide prioritizing their well-being, believing in the potential cost savings for healthcare systems and fostering healthier populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the global nutraceutical & vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical & Vaccine Market Segmental Analysis

Global Nutraceutical & Vaccine market is segmented by type, platform, and region. Based on type, the market can be segmented into nutraceutical, and vaccine. Based on platform, the market is segmented into adult and children. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Nutraceutical & Vaccine Market

A key catalyst propelling the global nutraceutical and vaccine market forward is the escalating focus on preventative healthcare. As awareness regarding the significance of preserving holistic wellness and warding off diseases continues to rise, there's an increasing need for products that provide health advantages and bolster the immune system. Consumers are proactively pursuing nutraceuticals and vaccines as integral components of their healthcare regimen. This surge is driven by evolving lifestyles, aging demographics, and the inclination to curtail healthcare expenditures by averting illnesses rather than addressing them post-manifestation.

Restraints in the Global Nutraceutical & Vaccine Market

One significant impediment facing the global nutraceutical and vaccine market lies in the strict regulatory frameworks and approval procedures. The journey from development to commercialization of nutraceuticals and vaccines demands meticulous testing, extensive clinical trials, and adherence to regulatory standards to guarantee safety, effectiveness, and quality. These procedures, albeit essential, often prove time-intensive and financially burdensome, particularly for smaller enterprises operating with constrained resources. The stringent regulatory environment may further lead to product launch delays and escalated compliance expenditures, consequently obstructing market expansion and stifling innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical & Vaccine Market

A significant market trend in the global nutraceutical and vaccine industry is the rising interest in personalized and targeted healthcare solutions. Consumers are now more inclined towards products that meet their unique health requirements and genetic predispositions. This trend is driven by technological advancements like genomics, personalized medicine, and data analytics, enabling customized approaches to nutrition and vaccination. Market participants are adapting to this shift by creating personalized nutraceuticals and vaccines, delivering bespoke formulations and treatment strategies to tackle individual health issues and enhance outcomes. This trend underscores the move towards precision healthcare, acknowledging the diverse health needs of individuals.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Nutraceutical & Vaccine Market by Type

Market Overview
Nutraceutical and Vaccine

Global Nutraceutical & Vaccine Market by End-User

Market Overview
Adult and Children

Global Nutraceutical & Vaccine Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments